stockrowLENSAR, Inc. (LNSR) vs Nyxoah SA (NYXH)
- LENSAR, Inc. LNSR 5.40 −1.82%
- Nyxoah SA NYXH 0.81 0.00%
LENSAR, Inc. and Nyxoah SA are both Medical Devices companies. Nyxoah SA is the larger, with a market value of $82.6M against $67.6M — 1.2× the size. Nyxoah SA has negative trailing earnings, so its P/E is not meaningful; LENSAR, Inc. trades at 3.9×. Nyxoah SA grew revenue faster over the last twelve months: 366.2% against 3.26%. LENSAR, Inc. has the higher net margin (57.6% vs −446.4%) and the lower return on invested capital (−379.0% vs −117.8%). Across the 18 metrics below, LENSAR, Inc. leads on 10 and Nyxoah SA on 8.
Valuation
Profitability
| Metric | LNSR | NYXH | Medical Devices median |
|---|---|---|---|
| Gross margin | 48.34% | 60.16% | 57.76% |
| Operating margin | (13.48%) | (391.25%) | (15.07%) |
| Net margin | 57.57% | (446.39%) | (14.45%) |
| Free cash flow margin | (12.29%) | (344.99%) | (3.88%) |
| Return on equity | (851.75%) | (124.41%) | (10.35%) |
| Return on assets | 49.58% | (68.23%) | (17.26%) |
| Return on invested capital | (379.01%) | (117.82%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack